Company Filing History:
Years Active: 2020-2022
Title: Laurence Bernard Peterson: Innovator in Immunology
Introduction
Laurence Bernard Peterson is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of immunology, particularly through his innovative work on fusion proteins. With a total of 3 patents, Peterson's inventions have the potential to impact therapeutic approaches in treating various diseases.
Latest Patents
Peterson's latest patents focus on interleukin-2 fusion proteins and their applications. The first patent describes fusion proteins of immunoglobulins and interleukin-2 (IL-2). This invention relates to polynucleotides encoding such fusion proteins, as well as vectors and host cells that contain these polynucleotides. The methods for producing these fusion proteins and their use in disease treatment are also covered. The second patent similarly addresses fusion proteins of immunoglobulins and mutant IL-2, which exhibit enhanced properties for therapeutic use, particularly in treating autoimmune diseases and immune-mediated inflammatory diseases.
Career Highlights
Throughout his career, Peterson has worked with prominent companies in the pharmaceutical industry, including Roche Glycart AG and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Some of Peterson's notable coworkers include Ralf Hosse and Christian Klein. Their collaboration has likely fostered a productive environment for research and development in the field of immunology.
Conclusion
Laurence Bernard Peterson's work in developing interleukin-2 fusion proteins showcases his innovative spirit and dedication to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of various diseases.